# Project 1: RENEWeb: Reaching-out to ENhance diet and Weight Control via the Web in Cancer Survivors

> **NIH NIH P01** · UNIVERSITY OF ALABAMA AT BIRMINGHAM · 2021 · $45,745

## Abstract

RENEWeb: Reaching-out to ENhancE diet and Weight Control via the Web in Cancer Survivors
Rates of obesity are high in the general population. Cancer survivors, however have even higher rates
because there are 13 distinct cancers for which obesity is a proven risk factor; plus, weight gain is a common
side effect with some cancer treatments. Given substantial evidence that obesity is a poor prognostic factor
that also associates with increased comorbidity, functional decline, and higher health care costs, the American
Society of Clinical Oncology (ASCO) issued a position statement urging intensified efforts to improve education
and resources, as well as advocating for research to determine optimal interventions and mechanisms of
action, and to increase access to resources and services for weight management among cancer survivors.
ASCO also underscored a particular need in underserved populations – a need also long expressed by the
National Cancer Institute (NCI). Specifically, the NCI points to gaps in addressing the needs of older cancer
survivors from minority groups who reside in rural areas. In addition, because almost all research in cancer
survivorship has been conducted in breast cancer survivors, both the NCI and ASCO urge research in
survivors of other types of cancer. The proposed study directly addresses the gaps identified by ASCO and
NCI. We will adapt a previous intervention entitled RENEW, which had proven success in promoting weight
loss and significantly improving the lifestyle behaviors and functional status of older survivors of colorectal,
breast, and prostate cancer using computer-tailored mailed print and telephone counseling intervention, by
delivering it more broadly through a web-based platform. The 6-month RENEWeb intervention will then be
tested in 326 survivors of 7 select obesity and physical activity related cancers, significant proportions of whom
will be older, rural, and minority. Using a 2-arm randomized controlled design, survivors will be evenly and
randomly assigned to either RENEWeb or a wait-listed control arm. The primary aim will be to determine
between-arm differences in weight loss. Secondary aims will be to assess the effects of the intervention on
other clinical outcomes (i.e., lean body mass, physical functioning and performance), quality of life, diet and
physical activity behaviors, and relevant biomarkers of inflammation and successful aging (i.e., c-reactive
protein, interleukin-6 and -10, interferon γ, and telomerase). Finally, we will identify the behavioral mechanisms
that drive the success of the intervention, as well as examine the characteristics of those who benefit most and
assess cost effectiveness. All of these efforts are ultimately directed toward improving health and
ascertaining effective interventions that have the broad reach necessary to help the most underserved
cancer survivors.

## Key facts

- **NIH application ID:** 10247779
- **Project number:** 5P01CA229997-04
- **Recipient organization:** UNIVERSITY OF ALABAMA AT BIRMINGHAM
- **Principal Investigator:** Wendy Demark-Wahnefried
- **Activity code:** P01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $45,745
- **Award type:** 5
- **Project period:** 2018-09-01 → 2024-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10247779

## Citation

> US National Institutes of Health, RePORTER application 10247779, Project 1: RENEWeb: Reaching-out to ENhance diet and Weight Control via the Web in Cancer Survivors (5P01CA229997-04). Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/grant/nih/10247779. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*